The inhibition of adjuvant disease in rats by the interferon-inducine agent pyran copolymer.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000998:Antiviral Agents / Q000097:blood; D001168:Arthritis / Q000188:drug therapy*; D004195:Disease Models, Animal; D005620:Freund's Adjuvant; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007372:Interferons / Q000096:biosynthesis*; D011714:Pyrans / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013163:Splenomegaly / Q000188:drug therapy; D014779:Virus Replication
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D011714:Pyrans; D005620:Freund's Adjuvant; D007372:Interferons